PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Capitalism and greed gave Britain its vaccine success, PM Johnson says

Tue, 23rd Mar 2021 21:51

* Johnson tries to row back from gaffe on greed

* Praises capitalism in vaccine lead

* UK state money developed the Oxford vaccine

* Communist China moved fast to develop a vaccine
(Adds context on Oxford vaccine)

By Costas Pitas

LONDON, March 24 (Reuters) - Capitalism and greed gave
Britain its success in vaccinating its population, Prime
Minister Boris Johnson told lawmakers in a closed meeting, a
remark that could rile up Brussels at a time when Britain faces
an EU threat to block vaccine imports.

"The reason we have the vaccine success is because of
capitalism, because of greed my friends," The Sun newspaper
quoted Johnson as telling Conservative lawmakers on a Zoom
meeting on Tuesday evening.

Johnson then tried to row back and said: "Actually I regret
saying it" and asked lawmakers repeatedly to "forget I said
that".

Britain has so far mounted the fastest COVID-19 vaccine
programme of any big country. But it now finds its programme
threatened by the EU, which has been far slower in rolling out
vaccines and faces a third wave of infections.

The European Commission is expected on Wednesday to extend
powers to block exports, a move that could hit supply of doses
bound for Britain. Johnson's remarks come after a week in which
British ministers have tried to calm the row.

Downing Street declined to comment on Johnson's remarks when
contacted by Reuters, but unidentified sources gave the BBC a
bizarre array of explanations.

The greed comment, according to the BBC's political editor
Laura Kuenssberg, was apparently a joke about one of his cabinet
colleagues, Chief Whip Mark Spencer, who was gobbling a cheese
and pickle sandwich while the prime minister spoke.

Johnson, Home Secretary Priti Patel said, was talking about
the success of pharmaceutical companies in developing a vaccine
shot in record time.

"Clearly the prime minister was actually referring to the
work that has taken place with pharmaceutical companies and how
we have led the way really in this vaccine development," said
Patel, who was not in the meeting.

Britain was one of several countries that developed a
COVID-19 vaccine shot in record time: the shot developed by
Oxford University and AstraZeneca was approved for use
on Dec. 30 by the British medicines regulator.

The British government helped fund the research, and
AstraZeneca has promised to market it on a not-for-profit basis.

Other vaccines around the world have been developed with
state funding, from Communist China and former communist Russia
to the capitalist United States.
(Reporting by Costas Pitas and Guy Faulconbridge; Editing by
Steve Orlofsky, Rosalba O'Brien, Kate Holton and Peter Graff)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.